Product image of Alunbrig (Brigatinib) supplied by GNH India

Alunbrig

Active Ingredient:
Brigatinib
Origin:
EU

Alunbrig (Brigatinib)

Alunbrig (Brigatinib) is an oral medication used to treat certain types of cancer. This guide provides key details about its uses, effects, and precautions.

Manufacturer / TM Owner

Takeda Pharma A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Alunbrig is primarily used in the treatment of non-small cell lung cancer (NSCLC). It is often prescribed for patients with specific genetic mutations who have progressed after other treatments. The medication works by targeting and inhibiting certain proteins involved in cancer cell growth. Patients and healthcare providers often discuss 'what is Alunbrig used for' in the context of advanced or metastatic NSCLC.

Side Effects

  • Common effects of Alunbrig may include nausea, fatigue, and cough. Some users also report diarrhea and increased blood pressure. These effects can vary in intensity and duration. It's important to monitor any persistent or severe symptoms and consult a healthcare professional.

Precautions & Warnings

  • Alunbrig should be handled with care, following the guidance of a healthcare provider. It is essential to inform your doctor about any pre-existing conditions or other medications you are taking. Pregnant women or those planning to become pregnant should discuss the risks and benefits with their healthcare provider.

Avoid Interactions

  • Alunbrig may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is advisable to avoid grapefruit and grapefruit juice, as they can affect how the body processes the medication. Always consult a healthcare provider before starting or stopping any medication while taking Alunbrig.

Frequently Asked Questions

Alunbrig is used to treat non-small cell lung cancer (NSCLC) in patients with specific genetic mutations who have progressed after other treatments.

Alunbrig is taken orally, typically once daily, as prescribed by a healthcare provider. It should be taken with or without food, but consistency in how it is taken can help maintain steady levels in the body.

Common side effects may include nausea, fatigue, cough, diarrhea, and increased blood pressure. These effects can vary in intensity and duration.

Alunbrig may interact with certain medications, so it's important to consult a healthcare provider before combining it with other drugs.

Pregnant women or those planning to become pregnant should discuss the risks and benefits of taking Alunbrig with their healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Brigatinib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT